FORT WORTH, Texas, March 4, 2019 /PRNewswire/ -- Differin®, a leading consumer acne brand within Galderma and Nestlé Skin Health, is excited to announce the second annual Retinoid Education Week, which officially commenced yesterday, Sunday, March 3. This week-long mission aims to educate those with acne about how retinoids have revolutionized the way people not only think about, but also treat their condition. Together with Walgreens, Differin plans to provide consumers with information to further help them understand how retinoids work to effectively treat acne.
"The Differin team remains deeply committed to educating acne sufferers about treating and preventing acne. By bringing consumers Retinoid Education Week for the second year in a row, we're showing our sustained commitment to helping them find the best and clinically proven ways to get clear, healthy looking skin," says June Risser, Vice President and General Manager, Consumer Business at Nestlé Skin Health. "With Walgreens' retail support during Retinoid Education Week, we have an even greater opportunity to educate the 50 million Americans affected by acnei on how this innovative ingredient can help treat and prevent acne, as well as how easily one can access this life-changing treatment option."
Differin Gel contains adapalene, the first and only FDA-approved, prescription-strength retinoid available over-the-counter without a prescription. This ingredient allows people with mild to moderate acne, or even occasional breakouts, achieve consistently clear skin they can count on at an affordable price. To help celebrate Retinoid Education Week, consumers can visit Walgreens and save $3 on Differin® Gel from March 3rd – 31st to start their journey to clear skin.
According to a 2018 study among adults ages 18-40ii, almost a third treat their acne too late by addressing blemishes reactively and only when one appears. However, according to Differin Consulting Dermatologist and Founder of Entière Dermatology, Dr. Melissa Kanchanapoomi Levin, reactively treating or spot treating is not the most effective course of treatment for acne sufferers.
"As tempting as it may be to try the latest spot treatment for an instant fix, it is best to treat the entire face and tackle pimples at the source by using a retinoid," explains Dr. Levin. "Retinoids have been proven to clear and prevent breakouts, which helps to improve texture and restore skin. It's the gold standard, and dermatologists like myself have been prescribing it for decades."
According to an online survey of 1,000 women ages 25-34iii, 89% of those who currently treat their acne think they are doing so correctly, yet two out of three of those same women admit to not having found an acne treatment that really works.
"I find that many of my patients who come in for acne concerns say they've tried everything to treat their adult acne to no avail," says Dr. Levin. "With Differin Gel now available over-the-counter, it's easier than ever to incorporate a retinoid into daily skincare routines. While not all retinoids are the same, Differin Gel was designed with tolerability in mind and is therefore a great starter retinoid for those new to the ingredient or with more sensitive skin."
This year, Differin is celebrating Retinoid Education Week with another robust marketing campaign, inclusive of TV and digital advertising, but also educating through PR, influencer marketing, social, as well as, in-store.
To learn more about how retinoids have revolutionized the way to treat acne, visit https://www.differin.com/learn/step-by-step-acne-treatment and follow @DifferinUS on Instagram and Facebook.
Differin®, one of the leading acne franchises within Nestlé Skin Health, was the first brand to receive FDA approval to make the power of prescription-strength, acne-fighting retinoids available over-the-counter, marking the newest ingredient in the OTC acne category in more than 30 years. Differin Gel OTC contains 0.1% adapalene, a safe and effective retinoid, which doctors have prescribed to more than 40 million people globally for more than 20 years.
With a commitment to providing effective acne solutions, the Differin portfolio also includes cleansers and moisturizers to support a healthy skincare routine. For more information, please visit www.differin.com.
Galderma, Nestlé Skin Health's medical solutions business, was created in 1981 and is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions, including leading brands Cetaphil® and Differin®. Galderma is a leader in the research and development of scientifically-defined and medically-proven solutions for the skin. Partnering with health care practitioners around the world to meet the skin health needs of people throughout their lifetime, the company contributes to Nestlé Skin Health's vision to change the way the world thinks about skin health. For more information, please visit www.galderma.com.
i Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E and others. The burden of skin diseases: 2004: A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. Journal of the American Academy of Dermatology, Vol. 55, Issue 3, p490-500 Published in issue September 2006. DOI: http://dx.doi.org/10.1016/j.jaad.2006.05.048
ii The 2018 Study of the Market for Acne Products Among Young Adults. October 2018. Multi-Sponsor Surveys, Inc.
iii Wakefield Research/Differin. 2017. Differin Survey. Unpublished Raw Data.